- Home
- REPX vs VALN Comparison
REPX vs VALN Comparison
Compare REPX & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPX
- VALN
- Stock Information
- Founded
- REPX 2016
- VALN 2012
- Country
- REPX United States
- VALN France
- Employees
- REPX N/A
- VALN N/A
- Industry
- REPX Oil & Gas Production
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- REPX Energy
- VALN Health Care
- Exchange
- REPX Nasdaq
- VALN Nasdaq
- Market Cap
- REPX 581.0M
- VALN 669.2M
- IPO Year
- REPX N/A
- VALN 2021
- Fundamental
- Price
- REPX $26.73
- VALN $11.53
- Analyst Decision
- REPX Strong Buy
- VALN Strong Buy
- Analyst Count
- REPX 1
- VALN 3
- Target Price
- REPX $47.00
- VALN $15.33
- AVG Volume (30 Days)
- REPX 121.6K
- VALN 95.5K
- Earning Date
- REPX 08-06-2025
- VALN 08-12-2025
- Dividend Yield
- REPX 5.68%
- VALN N/A
- EPS Growth
- REPX N/A
- VALN N/A
- EPS
- REPX 4.52
- VALN N/A
- Revenue
- REPX $392,885,000.00
- VALN $230,566,060.00
- Revenue This Year
- REPX N/A
- VALN $18.61
- Revenue Next Year
- REPX $9.48
- VALN $25.07
- P/E Ratio
- REPX $5.92
- VALN N/A
- Revenue Growth
- REPX N/A
- VALN 25.47
- 52 Week Low
- REPX $21.98
- VALN $3.62
- 52 Week High
- REPX $37.55
- VALN $11.51
- Technical
- Relative Strength Index (RSI)
- REPX 50.34
- VALN 77.09
- Support Level
- REPX $25.79
- VALN $10.11
- Resistance Level
- REPX $27.68
- VALN $11.18
- Average True Range (ATR)
- REPX 1.06
- VALN 0.41
- MACD
- REPX 0.11
- VALN 0.35
- Stochastic Oscillator
- REPX 52.93
- VALN 100.00
About REPX Riley Exploration Permian Inc.
Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations are in Kansas Properties and Tennessee Properties, among others.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.